highperformr logo

BIOCAD's Overview

Total employees800
HeadquartersSt. Petersburg
Founded2001

BIOCAD is one of Russia's leading innovative biopharmaceutical companies, combining a world-class research and development center, ultra-modern pharmaceutical and biotechnological manufacturing facilities, and an international-standard preclinical and clinical research infrastructure. The company is dedicated to the development, manufacturing, and marketing of original and biosimilar medicines, primarily in the fields of oncology, autoimmune diseases, and infectious diseases. BIOCAD's mission is to improve and prolong human lives by providing effective, safe, and affordable treatments. They have a strong focus on import substitution and export development, aiming to make advanced therapies accessible globally.

Where is BIOCAD's Headquarters?

HQ Function

Serves as the central hub for research and development, advanced manufacturing of biotechnological and pharmaceutical products, quality control, and corporate strategic operations.

Notable Features:

State-of-the-art R&D laboratories, modern GMP-compliant manufacturing facilities, advanced infrastructure for cell and gene therapy development. The campus is designed to foster innovation and collaboration.

Work Culture:

A dynamic and science-driven environment focused on innovation, collaboration, and continuous learning. Employees are often involved in cutting-edge research and development projects.

HQ Significance:

The Strelna campus is a cornerstone of BIOCAD's operations, enabling the full cycle of drug development from idea to commercial product, and representing a significant investment in Russia's biotech infrastructure.

Values Reflected in HQ: Innovation, scientific excellence, quality, and a commitment to advancing healthcare through cutting-edge technology and research.

Location:

BIOCAD supports a range of global functions including international business development, clinical trial management across multiple regions, product registration, marketing and sales in CIS countries, Southeast Asia, Latin America, the Middle East, and North Africa. The company actively seeks partnerships to expand its reach for its innovative and biosimilar drugs, with representative offices and operations in countries like Belarus, Kazakhstan, Vietnam, UAE, China, and Brazil.

Street Address:

Svyazi str., 34, lit. A, settlement Strelna

City:

St. Petersburg

State/Province:

N/A (Federal city)

Country:

Russia

BIOCAD's Global Presence

Moscow, Russia

Address: Smolenskaya pl., 3, Smolensky Passage, Moscow, 121099, Russia

To drive market penetration and stakeholder engagement within Russia's largest metropolitan area and federal administrative center.

Dubai, UAE

Address: BIOCAD DMCC, Unit No: 3680, DMCC Business Centre, Level No 1, Jewellery & Gemplex 3, Dubai, United Arab Emirates

To expand BIOCAD's presence and product portfolio in the growing MENA pharmaceutical market.

Shanghai, China

Address: BIOCAD (Shanghai) Pharmaceutical Co., Ltd., Room 207, Building 5, No.55 Chuanhe Road, Pudong New Area, Shanghai, China

To tap into the large Chinese pharmaceutical market and leverage China as a hub for regional expansion and research collaboration.

Minsk, Belarus

Address: 220005, Minsk, ave. Nezavisimosti 58V, office 403

To ensure availability of BIOCAD's innovative and biosimilar medicines in Belarus and support local healthcare needs.

Buying Intent Signals for BIOCAD

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Executive Team of BIOCAD

As of April 2025, BIOCAD' leadership includes:

Dmitry Morozov - General Director (CEO)
Roman Ivanov - Vice President of R&D and International Business Development
Irina Kenyukhova - Vice President, Quality and Pharmacovigilance
Pavel Yakutseni - Medical Director
Alexandra Grebennikova - Director of Business Development and Strategic Marketing Department

Investors of BIOCAD

BIOCAD has been backed by several prominent investors over the years, including:

Primarily Privately Held
Strategic Partnerships (e.g., Sberbank, VTB Capital for project financing)
Historically linked to Millhouse Capital and Pharmstandard

Executive New Hires/Exits in the Last 12 Months

Hire0
Exits0

Information on specific executive hires or exits at BIOCAD in the last 12 months is not widely publicized. The company maintains a stable core leadership team focused on long-term strategic goals. Any significant changes are typically announced via official press releases.

Technology (Tech Stack) used by BIOCAD

Discover the tools BIOCAD uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

BIOCAD Email Formats and Examples

BIOCAD's email format commonly follows a [lastname]_[first_initial]@biocad.ru pattern for its Russian operations. For international communications or specific departments, variations might exist, potentially using the biocadglobal.com domain.

[lastname]_[f]@biocad.ru

Format

morozov_d@biocad.ru

Example

85%

Success rate

News and media

BIOCAD Press ReleaseMay 23, 2024

BIOCAD presented data on the safety and efficacy of Divaras® at an international conference

BIOCAD shared results from clinical studies of Divaras® (INN: seniprutug) for ankylosing spondylitis at the XXXI Russian National Congress 'Man and Medicine.' The data confirmed the drug's high efficacy and favorable safety profile in long-term use....more

BIOCAD Press ReleaseApril 18, 2024

BIOCAD and the Ministry of Health of Nicaragua signed a cooperation agreement

BIOCAD and the Ministry of Health of Nicaragua signed a memorandum of cooperation aimed at improving the provision of medicines to the population of Nicaragua. The agreement focuses on expanding access to modern therapies for cancer and autoimmune diseases....more

BIOCAD Press ReleaseFebruary 29, 2024

BIOCAD received marketing authorization for Gladcentri® in Saudi Arabia

BIOCAD has obtained marketing authorization for its drug Gladcentri® (INN: eculizumab) in Saudi Arabia. This monoclonal antibody is used for treating paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome, marking a significant step in BIOCAD's expansion in the MENA region....more

Highperformr’s free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including BIOCAD, are just a search away.